The 2021 Family Law Index is out now Find out more

Company

Sofinnova Partners

Index

Wealth & Investing

Life Sciences

Location

London, United Kingdom

Advice type

Venture capital

Asset class

Alternative assets

Pharmaceuticals

Sector focus

Investments and Asset Management

Drug Manufacturers

Profile

Joe Anderson

Description

Joe Anderson has over 25 years’ experience in the life sciences industry, with a track record of generating investment returns.

He was partner at Abingworth LLP for 12 years (where he led venture-capital style investments in public companies), founded and managed public equities funds, was a director of Algeta (acquired by Bayer AG for $2.9 billion), Amarin plc, Cytos (merged with Kuros) and Epigenomics AG, CEO of Arix Bioscience and is currently a partner at Sofinovva. Anderson began his career at the Ciba (now Novartis) Foundation, before joining The Wellcome Trust in 1990 where he became head of strategy. He then moved to the City of London as a pharmaceuticals analyst at Dresdner Kleinwort Benson.

Rank: Top Recommended

Top Recommended 2021, Life Sciences

Share on